Relationship between cognitive functioning and frailty in older breast cancer survivors.

[1]  H. Cohen,et al.  Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study. , 2021, Journal of the National Cancer Institute.

[2]  S. Mohile,et al.  Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer , 2019, Journal of the American Geriatrics Society.

[3]  A. Wolff,et al.  Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer , 2019, Journal of the American Geriatrics Society.

[4]  T. Ahles,et al.  Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus , 2019, Molecular Neurobiology.

[5]  J. VanMeter,et al.  Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Cohen,et al.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Root,et al.  Cognitive Effects of Cancer and Cancer Treatments. , 2018, Annual review of clinical psychology.

[8]  David Smith,et al.  Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy , 2016, Cancer.

[9]  H. Cohen,et al.  Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) , 2016, Cancer.

[10]  L. Ercoli,et al.  Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient’s assessment of own functioning inventory , 2016, Supportive Care in Cancer.

[11]  T. Ahles,et al.  Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways , 2015, Behavioural Brain Research.

[12]  Jeanne S Mandelblatt,et al.  Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Christopher M. Nguyen,et al.  Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions , 2013, Psycho-Oncology.

[14]  C. Gundy,et al.  Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Supriya G Mohile,et al.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Nathaniel Mercaldo,et al.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.

[17]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[18]  J. Holland,et al.  Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective , 2006, Breast Cancer Research and Treatment.

[19]  L. Gavrilov,et al.  The Reliability‐Engineering Approach to the Problem of Biological Aging , 2004, Annals of the New York Academy of Sciences.

[20]  Cynthia Owsley,et al.  Timed Instrumental Activities of Daily Living Tasks: Relationship to Cognitive Function and Everyday Performance Assessments in Older Adults , 2002, Gerontology.

[21]  Elizabeth H Bradley,et al.  Understanding the treatment preferences of seriously ill patients. , 2002, The New England journal of medicine.

[22]  Andrew J Saykin,et al.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Katzman.,et al.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. , 1983, The American journal of psychiatry.

[24]  G. Fillenbaum,et al.  The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.

[25]  L. Radloff.  The CES-D Scale , 1977 .

[26]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[27]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[28]  A. Mitnitski,et al.  Aging as a process of deficit accumulation: its utility and origin. , 2015, Interdisciplinary topics in gerontology.

[29]  S. Schultz,et al.  Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. , 2010, The Journal of neuropsychiatry and clinical neurosciences.

[30]  W. Sturm,et al.  Neuropsychological assessment , 2007, Journal of Neurology.

[31]  P. Jacobsen,et al.  Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancer , 2005, Supportive Care in Cancer.